EQL Pharma AB
EQL | XSTO
Overview
Corporate Details
- ISIN(s):
- SE0005497732
- LEI:
- 549300Q8B2D2AE8GCW21
- Country:
- Sweden
- Address:
- Stortorget 1, 222 23 Lund
- Website:
- https://eqlpharma.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
EQL Pharma is an entrepreneurial pharmaceutical company focusing on simplicity and efficiency at all levels of the value chain in order to be able to deliver cost-efficient medicines of highest quality to pharmacies and hospitals, primarily in the Nordic region. The company conducts extensive development activities in collaboration with partners in Asia, Europe and India. Our strategy is to develop generic medicines in areas where the competition is limited, so-called niche generics. We do not focus on specific therapeutic areas, but rather on the opportunities we can identify in the Nordic market for prescription medicines sold in pharmacies or used in hospitals. Our entire business is based on us delivering the cheapest medicines to pharmacies and hospitals, in this way daily lowering the cost of high-quality drugs for patients and society.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-08 07:00 |
Annual Report
|
Swedish | 1.3 MB | |
| 2025-05-08 07:00 |
Annual Report
|
English | 1.3 MB | |
| 2025-03-07 08:30 |
Earnings Release
New financial targets for the period 2024/25 – 2028/29
|
English | 351.6 KB | |
| 2025-03-07 08:30 |
Earnings Release
Nya finansiella mål för perioden 2024/25 - 2028/29
|
Swedish | 291.7 KB | |
| 2025-02-24 09:24 |
Declaration of Voting Results & Voting Rights Announcements
Valberedning inför årsstämman 2025
|
Swedish | 352.0 KB | |
| 2025-02-24 09:24 |
Regulatory News Service
Nomination committee for the 2025 Annual General Meeting
|
English | 216.8 KB | |
| 2025-02-05 07:00 |
Quarterly Report
|
Swedish | 1.3 MB | |
| 2025-02-05 07:00 |
Quarterly Report
|
English | 1.3 MB | |
| 2025-01-31 12:35 |
Regulatory News Service
EQL Pharma AB slutför inkråmsförvärv av produktportfölj från Medilink A/S
|
Swedish | 319.0 KB | |
| 2025-01-31 12:35 |
Regulatory News Service
EQL Pharma AB completes the asset purchase of a product portfolio from Medilink…
|
English | 329.1 KB | |
| 2025-01-17 15:45 |
Capital/Financing Update
EQL Pharma AB successfully issues senior secured bonds
|
English | 323.8 KB | |
| 2025-01-17 15:45 |
Capital/Financing Update
EQL Pharma AB (publ) emitterar seniora säkerställda obligationer
|
Swedish | 341.6 KB | |
| 2025-01-13 08:00 |
Inside Information Statement
EQL Pharma AB (publ) contemplates to issue senior secured bonds and publishes p…
|
English | 328.5 KB | |
| 2025-01-13 08:00 |
Inside Information Statement
EQL Pharma AB (publ) överväger att emittera seniora säkerställda obligationer o…
|
Swedish | 346.0 KB | |
| 2024-12-10 15:09 |
Regulatory News Service
Correction: EQL Pharma AB (publ) signs an asset purchase agreement in respect o…
|
English | 333.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-17 | christer fåhraeus | Other | Sell | 100,000 | 8,620,000.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |